Raj Mehra - 12 Jan 2024 Form 4 Insider Report for SEELOS THERAPEUTICS, INC.

Role
President, Chief Executive Officer and Chairman of the Board of Directors, Director
Signature
/s/ Raj Mehra
Issuer symbol
N/A
Transactions as of
12 Jan 2024
Net transactions value
$0
Form type
4
Filing time
17 Jan 2024, 21:47:31 UTC
Previous filing
01 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SEEL Stock Option (right to buy) Award $0 +70,383 $0.000000 70,383 12 Jan 2024 Common Stock 70,383 $1.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option shall vest on January 12, 2025, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Remarks:

President, Chief Executive Officer and Chairman of the Board of Directors